Doctors warn Crohn's, arthritis patients will pay a price as Alberta pulls drug funding
Tuesday, December 17, 2019 - 10:20
in Mathematics & Economics
Doctors say 2,000 patients in Alberta will pay a price with the government's plan to stop funding Remicade, a drug used to treat people with Crohn's and colitis.